Aridis Pharmaceuticals, Inc. (ARDS)
OTCMKTS · Delayed Price · Currency is USD
0.0028
+0.0026 (1,300.00%)
At close: May 6, 2026
Aridis Pharmaceuticals Market Cap
Aridis Pharmaceuticals has a market cap or net worth of $149.3 thousand as of May 6, 2026. Its market cap has increased by 281,594.34% in one year.
Market Cap
149.30K
Enterprise Value
n/a
Revenue
22.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 14, 2018, Aridis Pharmaceuticals's market cap has decreased from 102.57M to 149.30K, a decrease of -99.85%. That is a compound annual growth rate of -57.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 149.30K | 86.67% |
| Dec 31, 2025 | 79.98K | 1,400.02% |
| Dec 31, 2024 | 5.33K | -99.83% |
| Dec 29, 2023 | 3.18M | -89.17% |
| Dec 30, 2022 | 29.39M | -10.24% |
| Dec 31, 2021 | 32.75M | -46.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regenicin | 15.35K |
| Syros Pharmaceuticals | 12.08K |
| ObsEva | 11.72K |
| TC Biopharm (Holdings) | 11.57K |
| Biostax | 10.71K |
| Trevena | 10.64K |
| GeneLink | 10.60K |
| Navidea Biopharmaceuticals | 10.00K |